Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
IMMP
IMMP
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IMMP News
Rosen Law Firm Investigates Immutep Securities Claims
3d ago
Globenewswire
Immutep Stock Plummets 90% After Phase III Trial Halt Recommendation
6d ago
PRnewswire
Rosen Law Firm Investigates Immutep Securities Claims
6d ago
Globenewswire
Investigation into Immutep Limited for Securities Fraud Claims
6d ago
Globenewswire
Rosen Law Firm Investigates Securities Claims for Immutep Ltd.
Mar 24 2026
PRnewswire
Immutep Faces Securities Claims Investigation
Mar 19 2026
Globenewswire
Immutep's TACTI-004 Trial Halted After Futility Analysis
Mar 18 2026
PRnewswire
Rosen Law Firm Investigates Securities Claims for Immutep Ltd.
Mar 18 2026
PRnewswire
Immutep Terminates NSCLC Trial for Efti
Mar 13 2026
Yahoo Finance
U.S. Stocks Rise in Morning Trade Amid Economic Slowdown
Mar 13 2026
Benzinga
Wall Street Analysts Adjust Ratings
Mar 13 2026
Benzinga
Immutep's Late-Stage Trial Halted Due to Futility Analysis
Mar 13 2026
seekingalpha
The Oncology Institute Reports Strong Q4 Results, Shares Surge
Mar 13 2026
Benzinga
Immutep Halts TACTI-004 Clinical Trial Following IDMC Recommendation
Mar 13 2026
NASDAQ.COM
Immutep's TACTI-004 Trial Reaches 50% Enrollment Milestone
Feb 06 2026
Newsfilter
Immutep's First LAG-3 Antibody Trial Shows Positive Phase I Results
Dec 22 2025
Benzinga
Show More News
